XML 49 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net income (loss) $ (442,716) $ 184,400
Adjustments to reconcile net income to net cash used in operating activities:    
Investment (income) loss 109,673 (62,150)
Depreciation and amortization 452 6,564
Equity-based compensation 5,365 14,329
Net realized and unrealized (gain) loss from consolidated funds’ investments 365,314 (51,298)
Amortization (accretion) of original issue and market discount of consolidated funds’ investments, net (7,828) (1,841)
Income distributions from corporate investments in funds and companies 2,401 45,392
Other non-cash items 46 1,420
Cash flows due to changes in operating assets and liabilities:    
Net cash used in operating activities (400,580) (56,511)
Cash flows from investing activities:    
Purchases of U.S. Treasury and other securities (7,221) (342,672)
Proceeds from maturities and sales of U.S. Treasury and other securities 7,141 431,573
Corporate investments in funds and companies (37,919) (8,593)
Distributions and proceeds from corporate investments in funds and companies 6,237 74,540
Purchases of fixed assets (84) (3,094)
Net cash (used in) provided by investing activities (31,846) 151,754
Cash flows from financing activities:    
Net cash provided by (used in) financing activities 483,768 (112,054)
Effect of exchange rate changes on cash (9,936) (1,384)
Net increase (decrease) in cash and cash-equivalents 41,406 (18,195)
Initial consolidation of funds 236 0
Cash and cash-equivalents, beginning balance 841,793 831,727
Cash and cash-equivalents, ending balance 883,435 813,532
Total cash and cash-equivalents 883,435 813,532
Oaktree Capital Group Excluding Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Decrease in deferred tax assets 1,100 0
(Increase) decrease in other assets 4,231 (1,453)
Decrease in net due from affiliates 95,323 82,452
Decrease in accrued compensation expense (51,773) (192,471)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (1,286) 24,218
Cash flows from financing activities:    
Capital contributions 19,817 0
Repurchase and cancellation of units 0 (9,925)
Distributions to Class A unitholders (21,445) (53,738)
Distributions to preferred unitholders (6,829) (6,829)
Distributions to OCGH unitholders (13,599) (68,366)
Distributions to non-controlling interests 0 (1,189)
Cash and cash-equivalents, ending balance 236,865 500,208
Total cash and cash-equivalents 236,865 500,208
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Increase (decrease) in accounts payable, accrued expenses and other liabilities (25,195) 3,979
(Increase) decrease in dividends and interest receivable 1,014 (2,060)
(Increase) decrease in due from brokers (8,221) 10,736
Increase in receivables for securities sold (77,436) (22,573)
(Increase) decrease in other assets (4,619) 266
Increase in payables for securities purchased 5,017 51,123
Purchases of securities (1,353,014) (694,115)
Proceeds from maturities and sales of securities 981,572 546,571
Cash flows from financing activities:    
Distributions to non-controlling interests (127,267) (62,641)
Payment of debt issuance costs (1,168) (768)
Contributions from non-controlling interests 463,547 80,653
Proceeds from debt obligations issued by CLOs 186,085 75,947
Repayment on debt obligations issued by CLOs (42,263) (65,198)
Borrowings on credit facilities 75,380 372,000
Repayments on credit facilities (48,490) (372,000)
Cash and cash-equivalents, ending balance 646,570 313,324
Total cash and cash-equivalents $ 646,570 $ 313,324